666. Antiretroviral Therapy: Current and Future Options
Session: Symposium: HIV State-of-the-Art
Friday, October 9, 2015: 8:30 AM
Room: 6--AB
Eric S. Daar, MD, Los Angeles Biomedical Research Institute At Harbor-UCLA Medical Center, Torrance, CA


Disclosures:

E. S. Daar, Abbvie: Consultant , Consulting fee
Bristol Myers Squibb: Consultant , Consulting fee
Gilead: Consultant and Research Contractor , Consulting fee and Research grant
Janssen: Consultant , Consulting fee
Merck: Consultant and Research Contractor , Consulting fee and Research grant
Teva: Consultant , Consulting fee
ViiV: Consultant and Research Contractor , Consulting fee and Research support

See more of: HIV State-of-the-Art
See more of: Symposium
Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.